IL324002A - תרכובות ביציקליות לעיכוב קטוהקסוקינאז - Google Patents

תרכובות ביציקליות לעיכוב קטוהקסוקינאז

Info

Publication number
IL324002A
IL324002A IL324002A IL32400225A IL324002A IL 324002 A IL324002 A IL 324002A IL 324002 A IL324002 A IL 324002A IL 32400225 A IL32400225 A IL 32400225A IL 324002 A IL324002 A IL 324002A
Authority
IL
Israel
Prior art keywords
compound
methyl
salt
azetidinyl
carbon
Prior art date
Application number
IL324002A
Other languages
English (en)
Inventor
Gavin WHITLOCK
Paul Glossop
Timothy P Rolph
Erik J Tillman
Original Assignee
Centennial Therapeutics Llc
Gavin WHITLOCK
Paul Glossop
Timothy P Rolph
Erik J Tillman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centennial Therapeutics Llc, Gavin WHITLOCK, Paul Glossop, Timothy P Rolph, Erik J Tillman filed Critical Centennial Therapeutics Llc
Publication of IL324002A publication Critical patent/IL324002A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL324002A 2023-05-31 2025-10-16 תרכובות ביציקליות לעיכוב קטוהקסוקינאז IL324002A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363470070P 2023-05-31 2023-05-31
PCT/US2024/031643 WO2024249612A1 (en) 2023-05-31 2024-05-30 Bicyclic compounds for ketohexokinase inhibition

Publications (1)

Publication Number Publication Date
IL324002A true IL324002A (he) 2025-12-01

Family

ID=91664008

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324002A IL324002A (he) 2023-05-31 2025-10-16 תרכובות ביציקליות לעיכוב קטוהקסוקינאז

Country Status (6)

Country Link
KR (1) KR20260022334A (he)
CN (1) CN121568939A (he)
AU (1) AU2024278772A1 (he)
IL (1) IL324002A (he)
MX (1) MX2025014314A (he)
WO (1) WO2024249612A1 (he)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
CN1378445B (zh) 1999-08-06 2013-02-06 得克萨斯系统大学评议会 药物释放生物可降解纤维植入物
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
KR102073048B1 (ko) 2015-12-29 2020-02-04 화이자 인코포레이티드 케토헥소키나제 억제제로서의 치환된 3-아자비시클로[3.1.0]헥산
TWI750685B (zh) 2019-06-17 2021-12-21 美商美國禮來大藥廠 二取代吡唑化合物
WO2022211595A1 (ko) * 2021-04-01 2022-10-06 주식회사 엘지화학 옥사디아졸 화합물 및 이를 포함하는 약제학적 조성물

Also Published As

Publication number Publication date
WO2024249612A1 (en) 2024-12-05
MX2025014314A (es) 2026-01-07
AU2024278772A1 (en) 2025-11-06
KR20260022334A (ko) 2026-02-19
CN121568939A (zh) 2026-02-24

Similar Documents

Publication Publication Date Title
US12570642B2 (en) GLP-IR modulating compounds
EP3573987B1 (en) Tyrosine amide derivatives as rho- kinase inhibitors
CN107614499B (zh) 吡啶并[3,4-d]嘧啶衍生物及其药学上可允许的盐
DK2857404T3 (en) IMIDAZO [1,2-b] PYRIDAZINE DERIVATIVES AS KINase INHIBITORS
IL266236A (he) טאו–פרוטאין ממוקד protacs ושיטות קשורות לשימוש
IL290408B1 (he) מאפננים של מווסת מוליכות טרנס–ממברנלי של סיסטיק פיברוזיס
IL323591A (he) תרכובות לפירוק ועיכוב של חלבון kras (g12d)
AU2018312836B2 (en) Novel heterocyclic compounds as CDK8/19 inhibitors
TW201242959A (en) Complement pathway modulators and uses thereof
JP2021511363A (ja) キナーゼ阻害剤としてのアミノピロロトリアジン
CA3120514A1 (en) Cyclic ureas
US11981658B2 (en) Substituted aminopyridine compounds as EGFR inhibitors
CN113677673B (zh) Trpc6的抑制剂
US20260034123A1 (en) Cdk2 inhibitors and methods of using the same
IL322849A (he) מעכבי אינטגרין אלפא 4 בתא 7 מקרוציקליים
IL323884A (he) תרכובות פירימידין דו-מותמרת לעיכוב קטוהקסוקינאז
IL324002A (he) תרכובות ביציקליות לעיכוב קטוהקסוקינאז
TW202510871A (zh) 經取代之雙環化合物
IL316254A (he) פירידו [d-3,2] פירימידינים והשימוש בהם כמעכבי hpk1
JP2025521719A (ja) c-MYC mRNA翻訳調節因子及び癌治療におけるその使用
WO2026013291A1 (en) Inhibitors of rna methyltransferase
HK1249502B (zh) 吡啶并[3,4-d]嘧啶衍生物及其药学上可允许的盐
HK1207374B (en) Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors